Inventory

6 Months Ended

Jun. 30, 2020

Inventory Disclosure [Abstract]

Inventory

Inventory

Components of inventory, net of reserves, as of June 30, 2020 and December 31, 2019 are as follows:

	June 30, 2020		December 31, 2019
Raw Materials	$	3,041,887	$	2,471,234
Work in Process	303,545		184,382
Finished Goods	2,032,745		1,432,290
Total	$	5,378,177	$	4,087,906

As of June 30, 2020, we classified $0.8 million of inventory as non-current, all of which was related to Triferic or the active pharmaceutical ingredient and raw materials for Triferic. As of June 30, 2020, we had total Triferic inventory aggregating $3.7 million, against which we had reserved $2.5 million.

The $1.2 million net value of Triferic inventory consisted of $0.2 million of Triferic Dialysate finished goods with expiration dates ranging from December 2020 to May 2021, $0.5 million of Triferic API with estimated remaining shelf life extending through 2023, and $0.5 million of raw materials for Triferic with estimated remaining shelf life extending beyond 2025.